122 related articles for article (PubMed ID: 19689630)
1. Medication adherence and significant others' support of consumers with schizophrenia in Australia.
McCann TV; Lu S
Nurs Health Sci; 2009 Sep; 11(3):228-34. PubMed ID: 19689630
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of antipsychotic medication taking in people with schizophrenia.
McCann TV; Deans C; Clark E; Lu S
Int J Ment Health Nurs; 2008 Dec; 17(6):428-38. PubMed ID: 19128290
[TBL] [Abstract][Full Text] [Related]
3. Adherence to multiple, prescribed medications in diabetic kidney disease: A qualitative study of consumers' and health professionals' perspectives.
Williams AF; Manias E; Walker R
Int J Nurs Stud; 2008 Dec; 45(12):1742-56. PubMed ID: 18701103
[TBL] [Abstract][Full Text] [Related]
4. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
McCann TV; Clark E; Lu S
J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
[TBL] [Abstract][Full Text] [Related]
5. Risk profiles for non-adherence to antipsychotic medications.
McCann TV; Boardman G; Clark E; Lu S
J Psychiatr Ment Health Nurs; 2008 Oct; 15(8):622-9. PubMed ID: 18803735
[TBL] [Abstract][Full Text] [Related]
6. Mediating role of illness representation among social support, therapeutic alliance, experience of medication side effects, and medication adherence in persons with schizophrenia.
Rungruangsiripan M; Sitthimongkol Y; Maneesriwongul W; Talley S; Vorapongsathorn T
Arch Psychiatr Nurs; 2011 Aug; 25(4):269-83. PubMed ID: 21784285
[TBL] [Abstract][Full Text] [Related]
7. A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia.
Boardman G; McCann T; Kerr D
J Adv Nurs; 2014 Oct; 70(10):2293-302. PubMed ID: 24628395
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
9. Results of a thematic analysis to explore the experiences of patients with schizophrenia taking antipsychotic medication.
Rofail D; Heelis R; Gournay K
Clin Ther; 2009 Jun; 31 Pt 1():1488-96. PubMed ID: 19698906
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
11. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
Maneesakorn S; Robson D; Gournay K; Gray R
J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
[TBL] [Abstract][Full Text] [Related]
12. Peers experience of delivering a problem-solving programme to enhance antipsychotic medication adherence for individuals with schizophrenia.
Boardman G; Kerr D; McCann T
J Psychiatr Ment Health Nurs; 2015 Aug; 22(6):423-30. PubMed ID: 25944402
[TBL] [Abstract][Full Text] [Related]
13. Wanting to be heard: mental health consumers' experiences of information about medication.
Happell B; Manias E; Roper C
Int J Ment Health Nurs; 2004 Dec; 13(4):242-8. PubMed ID: 15660592
[TBL] [Abstract][Full Text] [Related]
14. Community treatment orders and antipsychotic long-acting injections.
Lambert TJ; Singh BS; Patel MX
Br J Psychiatry Suppl; 2009 Nov; 52():S57-62. PubMed ID: 19880919
[TBL] [Abstract][Full Text] [Related]
15. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
16. Accessing health care professionals about antipsychotic medication related concerns.
Boardman GH; McCann TV; Clark E
Issues Ment Health Nurs; 2008 Jul; 29(7):739-54. PubMed ID: 18592424
[TBL] [Abstract][Full Text] [Related]
17. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
18. The relationship of antipsychotic medication class and adherence with treatment outcomes and costs for Florida Medicaid beneficiaries with schizophrenia.
Becker MA; Young MS; Ochshorn E; Diamond RJ
Adm Policy Ment Health; 2007 May; 34(3):307-14. PubMed ID: 17211716
[TBL] [Abstract][Full Text] [Related]
19. Choosing to use compared to taking medication: the meaning of medication as described by people who experience schizophrenia.
Liersch-Sumskis S; Moxham L; Curtis J
Perspect Psychiatr Care; 2015 Apr; 51(2):114-20. PubMed ID: 24787648
[TBL] [Abstract][Full Text] [Related]
20. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
